A single-blind, randomized, placebo-controlled study in healthy men and women to determine the effect of single subcutaneous injections of GSK716155 [albiglutide] on gastric emptying time for solid and liquid components of a meal.

Trial Profile

A single-blind, randomized, placebo-controlled study in healthy men and women to determine the effect of single subcutaneous injections of GSK716155 [albiglutide] on gastric emptying time for solid and liquid components of a meal.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs Albiglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Oct 2008 Actual start date changed from Nov 2007 to Dec 2007 as reported by Clinicaltrials.gov.
    • 18 Aug 2008 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top